Showing results (151-160 of 560) with videos related to
Sort By:
Pageof 56
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1990
Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitroH Blomgren, M Hallström, H HillgrenInternational Archives of Allergy and Applied Immunology|January 1, 1978
Induction of specific unresponsiveness against the C3H M1s=antigen in mice, increase of suppressive capacity of C3H X CBA F1-lymphocytes after sensitization against CBA lymphoid cellsB Lilliehöök, H Blomgren, H JacobssonCancer|October 1, 1979
The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with Hodgkin's diseaseE Baral, H Blomgren, I JuhlinCancer Immunology, Immunotherapy : CII|January 1, 1986
Relation between the site of primary intracranial tumors and mitogenic responses of blood lymphocytesH Blomgren, U Blom, H UlénInternational Journal of Cancer|October 15, 1978
Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferonS Einhorn, H Blomgren, H StranderScandinavian Journal of Immunology|January 1, 1976
Partial tolerant state against H-2 disparate cells. No impaired specific reactivity in MLC, GVH, or antibody productionH Jacobsson, B Lilliehöök, H BlomgrenScandinavian Journal of Immunology|January 1, 1976
Complex nature of the production of 'effector' cells and their interaction with target cells in the M-antigen system of the mouseB Lilliehöök, H Jacobsson, H BlomgrenAnticancer Research|March 1, 1991
Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro. Its potential use in the treatment of superficial bladder cancerH Blomgren, M Hallström, H HillgrenAnticancer Research|July 1, 1985
Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor typeH Blomgren, U Blom, H UllénBiomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1980
Changes of the blood lymphocyte population in cancer patients treated with bestatin, a new immunomodulator. A phase I studyH Blomgren, L E Strender, F EdsmyrPageof 56